glp-1 therapies success rate Q&A: Long-term of hinges on more than just a prescription Prime Therapeutics' leading research shows

Journal of Bone and Mineral Research

While all plans include free text-based coaching, much of it involves AI responses monitored by a licensed coach

GLP-1 receptor agonists effect on heart failure outcomes has differed by heart failure subtype

(This is based on when you started the medication not your current weight) BMI of 35 or higher when you started, OR BMI of 30 or higher AND a serious heart or kidney condition, OR BMI of 27 or higher AND a history of heart attack, stroke, or pre-diabetes 3

both conditions are thought to represent a state of glomerular hypertension that damages the glomerular capsule [12]